NewsSOS
Mar Vista Investment Partners, LLC cited a loss of investor confidence in Stryker Corporation's near-term growth trajectory as the primary driver behind the company's underperformance during the third quarter of 2026.
The firm noted that this sentiment did not reflect a deterioration in the long-term franchise of the medical technology company, which operates across MedSurg, Neurotechnology, and Orthopaedics segments.
Stryker Corporation closed at $276.97 on October 8, 2026, establishing a market capitalization of $106.24 billion.
The stock recorded a year-to-date pullback of approximately 21.20%, trading within a 52-week range that spanned from $267.00 to $392.55. Trailing twelve-month revenue for the company stood at $25.84 billion.
Keep reading